Your browser doesn't support javascript.
loading
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Opdam, M; van der Noort, V; Kleijn, M; Glas, A; Mandjes, I; Kleiterp, S; Hilbers, F S; Kruger, D T; Bins, A D; de Jong, P C; Schiphorst, P P J B M; van Dalen, T; Flameling, B; Rietbroek, R C; Beeker, A; van den Heiligenberg, S M; Bakker, S D; Wymenga, A N M; Oving, I M; Bijlsma, R M; van Diest, P J; Vermorken, J B; van Tinteren, H; Linn, S C.
Afiliación
  • Opdam M; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
  • van der Noort V; Biometrics Department, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Kleijn M; Medical Affairs, Agendia NV, Amsterdam, Netherlands.
  • Glas A; Medical Affairs, Agendia NV, Amsterdam, Netherlands.
  • Mandjes I; Biometrics Department, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Kleiterp S; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
  • Hilbers FS; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
  • Kruger DT; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
  • Bins AD; Department of Medical Oncology, Amsterdam UMC, Amsterdam, Netherlands.
  • de Jong PC; Department of Medical Oncology, Sint-Antonius Hospital, Nieuwegein, Netherlands.
  • Schiphorst PPJBM; Department of Internal Medicine, Streekziekenhuis Koningin. Beatrix, Winterswijk, Netherlands.
  • van Dalen T; Department of Surgery, Diakonessenhuis, Utrecht, Netherlands.
  • Flameling B; Department of Medical Oncology, OLVG, Amsterdam, Netherlands.
  • Rietbroek RC; Department of Internal Medicine, Red Cross Hospital, Beverwijk, Netherlands.
  • Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp, Netherlands.
  • van den Heiligenberg SM; Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, Netherlands.
  • Bakker SD; Department of Internal Medicine, Zaans Medisch Centrum, Zaandam, Netherlands.
  • Wymenga ANM; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, Netherlands.
  • Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, the Netherlands.
  • Bijlsma RM; Department of Medical Oncology, UMCU, Utrecht, Netherlands.
  • van Diest PJ; Department of Pathology, UMCU, Utrecht, Netherlands.
  • Vermorken JB; Department of Medical Oncology, University Hospital Antwerp (UZA), Edegem, Belgium.
  • van Tinteren H; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Linn SC; Biometrics Department, Netherlands Cancer Institute, Amsterdam, Netherlands.
Breast Cancer Res Treat ; 194(2): 265-278, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35587322
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos